Cancer Family
Neuroepithelial Neoplasm
CI-CAN-00000287Explore in graph →
Non-malignant811 active trials6 approved drugs154 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000287Explore in graph →
Clinical trials
2,935 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06720727 | Craniospinal Irradiation in Histone AlteRed Midline Glioma(CHARM) | recruiting | N/A | 32 | Tata Memorial CentreOTHER | 1 | Jan 20, 2025 | clinicaltrials |
| NCT03717142 | Feasibility of the LUM Imaging System for Detection of Cancer to the Brain | terminated | N/A | 4 | Lumicell, Inc.INDUSTRY | 1 | Jan 15, 2025 | clinicaltrials |
| Seizures During Radiotherapy for High-grade Gliomas(SURF-ROGG) |
| terminated |
| N/A |
| 23 |
| University Hospital Schleswig-HolsteinOTHER |
| 1 |
| Jan 15, 2025 |
| clinicaltrials |
| NCT05296122 | Safety and Feasibility of MR-guided Laser Thermal Ablation of Brain Lesions | completed | N/A | 14 | Clinical Laserthermia Systems ABINDUSTRY | 1 | Jan 15, 2025 | clinicaltrials |
| NCT04539574 | An Investigational Scan (7T MRI) for the Imaging of Central Nervous System Tumors | completed | N/A | 50 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 8, 2025 | clinicaltrials |
| NCT06764537 | Evaluation of in Vitro Antitumor Activity of GD2 CAR-T Cells in Glioblastoma(BOOSTCAR) | not yet recruiting | N/A | 18 | Central Hospital, Nancy, FranceOTHER | 1 | Jan 8, 2025 | clinicaltrials |
| NCT06753617 | Cryoablation of Brain Neoplasm | enrolling by invitation | N/A | 20 | Erasmus Medical CenterOTHER | 1 | Dec 31, 2024 | clinicaltrials |
| NCT06740097 | Feasibility of Aspirate Tissue Monitoring in Neuro-oncological Surgery(ATM GBM INT) | recruiting | N/A | 50 | Kuopio University HospitalOTHER | 2 | Dec 18, 2024 | clinicaltrials |
| NCT06740955 | Hypofractionated Radiotherapy | recruiting | N/A | 420 | The First Hospital of Jilin UniversityOTHER | 1 | Dec 18, 2024 | clinicaltrials |
| NCT06116903 | Clinical Relevance of Detecting Molecular Abnormalities in Glial Tumor Exosomes(ExoGLIE) | recruiting | N/A | 60 | University Hospital, LimogesOTHER | 1 | Dec 13, 2024 | clinicaltrials |
| NCT05015543 | Physical Training in Glioblastoma Patients During Cytotoxic Therapy(MMH) | completed | N/A | 54 | University Hospital MuensterOTHER | 1 | Dec 12, 2024 | clinicaltrials |
| NCT04109209 | Psychological Intervention For Brain Tumor Caregivers | completed | N/A | 120 | Massachusetts General HospitalOTHER | 1 | Dec 5, 2024 | clinicaltrials |
| NCT06713395 | PERMA-Based Intervention on Negative Emotions, Adherence, and Complications in Postoperative Glioma Patients(Glioma) | completed | N/A | 124 | Yang HuangOTHER_GOV | 1 | Dec 3, 2024 | clinicaltrials |
| NCT04726397 | UNIty-Based MR-Linac Guided AdapTive RadiothErapy for High GraDe Glioma: a Phase 2 Trial(UNITED) | completed | N/A | 108 | Sunnybrook Health Sciences CentreOTHER | 1 | Nov 29, 2024 | clinicaltrials |
| NCT06161610 | Recurrent High Grade Glioma Treated by LITT(REGALITT) | recruiting | N/A | 135 | Beijing Tiantan HospitalOTHER | 1 | Nov 29, 2024 | clinicaltrials |
| NCT06043765 | Reducing Cognitive Impairment in Glioma with Repetitive Transcranial Magnetic Stimulation and Cognitive Strategy Training(TRUE-GRIT) | recruiting | N/A | 16 | Linda DouwOTHER | 1 | Nov 18, 2024 | clinicaltrials |
| NCT03964909 | Resting-State Functional MRI in Glioma Patients Before and After Surgery | completed | N/A | 29 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 15, 2024 | clinicaltrials |
| NCT03735498 | Psychological Intervention for Caregivers of Patients With Malignant Gliomas | completed | N/A | 13 | Massachusetts General HospitalOTHER | 1 | Nov 13, 2024 | clinicaltrials |
| NCT03922984 | Non-Contrast Perfusion Using Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in Glioblastoma | completed | N/A | 43 | University of Texas Southwestern Medical CenterOTHER | 1 | Oct 22, 2024 | clinicaltrials |
| NCT04461938 | Characterization of Metabolic Changes in the Glioma Tumor Tissue Induced by Transient Fasting (ERGO3)(ERGO3) | active not recruiting | N/A | 30 | Goethe UniversityOTHER | 1 | Oct 17, 2024 | clinicaltrials |
| NCT03926507 | F18 Fluciclovine PET/CT in Assessing Tumor Volume and Radiation Therapy Response in Patients With Glioblastoma Undergoing Surgery | completed | N/A | 12 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 9, 2024 | clinicaltrials |
| NCT06623565 | Extensive Resection of Malignant Brain Tumors Using Advanced Imaging Techniques(NEXTFRONTIER) | recruiting | N/A | 30 | Amsterdam UMC, location VUmcOTHER | 1 | Oct 2, 2024 | clinicaltrials |
| NCT03278249 | Feasibility Study of Modified Atkins Ketogenic Diet in the Treatment of Newly Diagnosed Malignant Glioma | completed | N/A | 12 | University of CincinnatiOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT03284268 | Evaluate Safety and the Oncolitic Adenovirus VCN-01 Activity in Patients With Refractory Retinoblastoma(RTB) | completed | N/A | 13 | Fundació Sant Joan de DéuOTHER | 1 | Aug 27, 2024 | clinicaltrials |
| NCT06572475 | USPIO Enhanced MR Imaging in CNS Tumours (UMIC)(UMIC) | recruiting | N/A | 17 | Northern Care Alliance NHS Foundation TrustOTHER | 1 | Aug 27, 2024 | clinicaltrials |
| NCT01923922 | CT Perfusion in the Prognostication of Cerebral High Grade Glioma | completed | N/A | 48 | Nova Scotia Health AuthorityOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT06563024 | 18F-FET PET/CT in the Management of Glioma | completed | N/A | 36 | Buddhist Tzu Chi General HospitalOTHER | 1 | Aug 20, 2024 | clinicaltrials |
| NCT06038604 | Glioblastoma Psychosocial Support Program | completed | N/A | 11 | Duke UniversityOTHER | 1 | Jul 31, 2024 | clinicaltrials |
| NCT05990556 | Research on the Safety and Efficacy of Blocking Dural Blood Supply in Glioblastoma Patients | recruiting | N/A | 20 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Jul 24, 2024 | clinicaltrials |
| NCT02441322 | Evaluating Therapeutic Response to Novo-TTF | completed | N/A | 30 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jul 19, 2024 | clinicaltrials |
| NCT06480721 | FET-PET-Guided Management of Pseudoprogression in Glioblastoma(FET-POPPING) | not yet recruiting | N/A | 144 | Veerle RuijtersOTHER | 1 | Jun 28, 2024 | clinicaltrials |
| NCT06454097 | Study on Radiogenomics Features Associated With Radiochemotherapy Sensitivity in Gliomas | unknown | N/A | 200 | Beijing Tiantan HospitalOTHER | 1 | Jun 12, 2024 | clinicaltrials |
| NCT04604158 | Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients | completed | N/A | 38 | Gillian GreshamOTHER | 1 | May 21, 2024 | clinicaltrials |
| NCT02613988 | Advanced MR Imaging as Predictor of Treatment Response in Newly Diagnosed Glioblastomas | unknown | N/A | 100 | Asan Medical CenterOTHER | 1 | May 14, 2024 | clinicaltrials |
| NCT05768087 | Escalated Dose Proton Therapy Within the Multimodality Treatment of Glioblastoma Patients | recruiting | N/A | 36 | University of AarhusOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT05727605 | Neurocognition After Radiotherapy in CNS- and Skull-base Tumors(NARCiS) | recruiting | N/A | 120 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT06381726 | Personalized Rendering of Motor System Functional Plasticity Potential to Improve Glioma Resection and Quality of Life | recruiting | N/A | 400 | University of MilanOTHER | 1 | Apr 24, 2024 | clinicaltrials |
| NCT06368934 | Sub-lobectomy for IDH Wild-type and TERT Promoter Mutant Glioblastoma | not yet recruiting | N/A | 326 | Huashan HospitalOTHER | 1 | Apr 16, 2024 | clinicaltrials |
| NCT06363162 | Evaluate the Effectiveness and Safety of Raman IVD Analyzer in the Molecular Diagnosis of Gliomas During Surgery | unknown | N/A | 200 | Beijing Tiantan HospitalOTHER | 1 | Apr 12, 2024 | clinicaltrials |
| NCT04556929 | Enhanced Detection in Glioma Excision(EDGE) | terminated | N/A | 4 | University of OxfordOTHER | 1 | Mar 22, 2024 | clinicaltrials |
| NCT03935269 | Cereset for Caregivers(CERESET) | withdrawn | N/A | 0 | Wake Forest University Health SciencesOTHER | 0 | Mar 20, 2024 | clinicaltrials |
| NCT06215495 | A Novel Target Delineation Scheme in High-grade Glioma Patients: a Randomized Single-blind Clinical Trial | recruiting | N/A | 88 | Zhujiang HospitalOTHER | 1 | Mar 15, 2024 | clinicaltrials |
| NCT03712293 | ExAblate Blood-Brain Barrier Disruption for Glioblastoma in Patients Undergoing Standard Chemotherapy | completed | N/A | 9 | InSightecINDUSTRY | 1 | Mar 5, 2024 | clinicaltrials |
| NCT01505569 | Auto Transplant for High Risk or Relapsed Solid or CNS Tumors | completed | N/A | 44 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Feb 26, 2024 | clinicaltrials |
| NCT06271421 | NanoTherm In Adjuvant Therapy of Glioblastoma Multiforme(ANCHIALE) | recruiting | N/A | 100 | Poznan University of Medical SciencesOTHER | 1 | Feb 26, 2024 | clinicaltrials |
| NCT04530006 | Acetyl-Amantadine as a Biomarker in Patients With Glioblastoma | unknown | N/A | 20 | CancerCare ManitobaOTHER | 1 | Feb 23, 2024 | clinicaltrials |
| NCT05604365 | FearLess in Cognitively Intact Patients With Glioma(FearLess) | completed | N/A | 22 | Virginia Commonwealth UniversityOTHER | 1 | Feb 9, 2024 | clinicaltrials |
| NCT05672082 | Contribution of [18F]DPA-714 PET for Grading and Exploration of the Inflammatory Microenvironment of Glioma.(INFLAGLI) | withdrawn | N/A | 0 | Center Eugene MarquisOTHER | 0 | Feb 8, 2024 | clinicaltrials |
| NCT06241391 | Ga-68 Prostate Specific Membrane Antigen PET/CT in Gliomas | unknown | N/A | 35 | All India Institute of Medical Sciences, BhubaneswarOTHER | 1 | Feb 8, 2024 | clinicaltrials |
| NCT05373381 | The KetoGlioma (Ketogenic Glioma) Study | withdrawn | N/A | 0 | Tufts Medical CenterOTHER | 1 | Feb 2, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Jan 20, 2025source: clinicaltrials